Asymchem

Asymchen combines molecular biology technology

Asymchen combines molecular biology technology, fermentation technology and process development technology to provide customers with carbapenems, cGMP APIs and other products used in anti-viral, anti-cancer, cardiovascular and cerebrovascular diseases, diabetes and other major diseases, and cooperates with Novartis, Bristol-Myers Squibb, AstraZeneca and GlaxoSmithKline.

Sector

Healthcare

Industry

Biotech/Pharma

Sub-industry

-

Founded

Oct 1, 1998

HQ location

Tianjin, China

Legal name

Asymchem Laboratories (Tianjin) Co., Ltd.

Employees

1001-5000

Briefing Oct 19, 2021 10:11 AM · Healthcare

Cro stocks rose in early trading

See more